TRANSTHERA

TransThera Sciences (Nanjing), Inc. is an R&D driven, clinical-stage, global biopharmaceutical company focusing on discovering and developing innovative small molecule therapies for oncology, inflammatory and cardiovascular diseases... Our focus on oncology is to discover and develop highly innovative drugcandidates with differentiated attributes to address challenges faced by patientswith hard-to-treat solid tumors and hematological malignancies or those who haveacquired or developed resistance to prior standard therapies. To this end, we havecontinued to build a balanced oncology pipeline that is expected to fulfilladditional INDs over time, churning out novel candidates into the clinicalstage. Upon establishing a robust and diverse oncology pipeline, we will alsoexplore to combine the internally developed clinical candidates mechanically,strategically, and commercially, to maximize the strength and achieve full lifecyclemanagement of each asset. Our oncology assets includes the..

Also known as: TransThera Sciences (Nanjing), TransThera Sciences (Nanjing), Inc.